Event Type
Disclosure
Mandatory
Variant
8-K
. Results of Operations and Financial Condition. In connection with the press release described in Item 8.01 below, on January 12, 2026, Rigel Pharmaceuticals,
. Other Events. On January 12, 2026, Rigel issued a press release titled “Rigel Provides Business Update and 2026 Outlook.” A copy of the press release is attac
. Financial Statements and Exhibits. (d) Exhibits. Exhibit Description 99.1 Press Release, dated January 12, 2026, titled “Rigel Provides Business Update and 20